Screener
Iovance Biotherapeutics, Inc. IOVA Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (51,905) | (113,774) | (132,948) | (234,995) |
| Other income | ||||
| Interest and other income, net | 3,217 | 4,104 | 4,550 | 7,324 |
| Net Loss before income taxes | $(48,688) | $(109,670) | $(128,398) | $(227,671) |
| Income tax benefit (expense) | 1,373 | (1,988) | 2,038 | (150) |
| Net Loss | $(47,315) | $(111,658) | $(126,360) | $(227,821) |
| Net Loss Per Share of Common Stock, Basic and Diluted | $(0.11) | $(0.33) | $(0.29) | $(0.69) |
| Weighted Average Shares of Common Stock Outstanding, Basic and Diluted | 450,189 | 334,511 | 434,437 | 328,721 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s pre-tax income?
- Iovance Biotherapeutics, Inc. (IOVA) reported pre-tax income of -$48.69M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s pre-tax income changed year-over-year?
- Iovance Biotherapeutics, Inc.'s pre-tax income increased by 55.6% year-over-year, from -$109.67M to -$48.69M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s pre-tax income has grown at a 3.5% compound annual growth rate (CAGR), from -$342.25M to -$393.05M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Iovance Biotherapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude